Hyperphosphatemia

·MeSH: Hyperphosphatemia

4 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
ap301	West Pharmaceutical Services Inc. (WST)
ferric	KERYX BIOPHARMACEUTICALS INC (KERYX)
ferric citrate	Akebia Therapeutics, Inc. (AKBA)

BLA Filed(1)

Drug	Company
oxylanthanum carbonate	Unicycive Therapeutics, Inc. (UNCY)

BioSniper tracks 4 drugs in development for Hyperphosphatemia across 4 companies.

There are 2 clinical trials targeting Hyperphosphatemia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.